HCPLive Network
$header$

$title$

| Wednesday, December 31, 1969


RELATED ARTICLES
If investors want better outcomes, they would be better served if capital were allocated by diverse teams. And the issue is not just about white males. When a team or market is dominated by any ethnicity, it tends to make worse decisions.
The issue of transparency in healthcare, particularly where pricing and payment information is concerned, has been widely debated for years. Is there a benefit to making this information readily available to the general public?
Only if you know where to shop, goes the old punch line. But a recent Wall Street Journal article cites new research on the long-argued subject that is worth riffing upon.
RECENT CLINICAL ARTICLES
Study results published in the European Respiratory Journal show that rates of inflammatory bowel disease (IBD) incidence have significantly increased in individuals with asthma or chronic obstructive pulmonary disease (COPD).
Regeneron Pharmaceuticals, Inc. and Sanofi recently announced the US food and Drug Administration (FDA) granted Breakthrough Therapy designation to dupilumab, a fully-human monoclonal antibody, to treat adults suffering from moderate to severe atopic dermatitis (AD)who had an insufficient response to or who were not suitable for topical prescription therapy.
Advanced life support given by paramedics to cardiac arrest victims may cost lives rather than save them, while the best treatment might just be good cardiopulmonary resuscitation given by paramedics or emergency medical technicians and getting the patient to the hospital as fast as possible. These findings were published online Nov. 24 in JAMA Internal Medicine.